Cationic Steroidal Antimicrobials for Sporicidal Activity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Spore-forming bacteria, such as Bacillus and Clostridium species, pose challenges due to their extreme resistance to environmental stressors, making their elimination in industrial and medical settings difficult, as conventional sporicidal agents are often toxic to humans and ineffective against their resilient spores.
Innovation Solution
The use of cationic steroidal antimicrobial (CSA) compounds, also known as ceragenins, which are synthetically produced small molecules that interact with and disrupt the spore structure, bypassing the spore's impermeability and damaging the DNA, thereby killing or deactivating the spores without relying on oxidation or acidic conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional sporicidal agents (oxidizing agents and acid solutions) are used to kill spores, then spore elimination effectiveness is improved, but human toxicity increases
Solution Approach 1:
The patent changes the chemical parameters of sporicidal agents by using cationic steroidal antimicrobials with specific molecular structures (steroid backbone with cationic functional groups) instead of traditional oxidizing agents or acids. This parameter change maintains sporicidal effectiveness while reducing human toxicity.
Solution Approach 2:
The invention uses composite molecular structures combining steroid backbones with cationic functional groups (amino, guanidino, or other charged groups) to create的新型 sporicidal agents that possess both effective spore-killing capability and reduced human toxicity compared to conventional agents.
2Reliability
If harsh chemical agents (oxidizing agents and acids) are used to damage spore membranes, then spore death is achieved, but applicability is reduced due to toxicity and harsh conditions
Solution Approach 1:
The patent modifies the chemical parameters of sporicidal agents by replacing harsh oxidizing agents and acids with cationic steroidal antimicrobials that operate under milder conditions, expanding the range of suitable applications while maintaining spore-killing effectiveness.
3Reliability
If enzymes in spore coat (superoxide dismutase) are present to detoxify oxidizing agents, then oxidizing agent effectiveness is reduced, but alternative non-oxidizing sporicidal agents are needed
Solution Approach 1:
Instead of using oxidizing agents that are neutralized by spore enzymes, the patent inverts the approach by using cationic steroidal antimicrobials that work through a different mechanism (interacting with spore membranes and DNA), thereby avoiding the detoxification problem entirely.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
CSA compounds effectively kill or deactivate spores on surfaces and in food products, reducing food spoilage and the risk of foodborne illnesses, while being safe and non-toxic to humans and animals, thus providing a safer alternative to traditional sporicidal agents.
Implementation Method 1
the cationic nature of the CSA compounds enables them to interact with and disrupt the spore structure, bypassing the spore's impermeability
Data Source
AI summary
This disclosure relates to sporicidal compositions and uses thereof. The sporicidal compositions include one or more cationic steroidal antimicrobials (CSAs). The sporicidal compositions may be applied to an object to kill or deactivate bacterial spores contacting the sporicidal composition. The object may be a food product, food processing equipment, industrial equipment, or healthcare facility objects. The sporicidal composition may be administered to a subject that has, is suspected to have, or is at risk for an infection associated with spore-forming bacteria.